Total Payments
$582,513
2024 Payments
$153,050
Companies
38
Transactions
1,329
Medicare Patients
392
Medicare Billing
$25,951
Payment Breakdown by Category
Other$449,430 (77.2%)
Travel$88,851 (15.3%)
Food & Beverage$26,202 (4.5%)
Consulting$17,410 (3.0%)
Education$619.60 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $449,430 | 175 | 77.2% |
| Travel and Lodging | $88,851 | 184 | 15.3% |
| Food and Beverage | $26,202 | 952 | 4.5% |
| Consulting Fee | $17,410 | 7 | 3.0% |
| Education | $619.60 | 11 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ViiV Healthcare Company | $493,626 | 622 | $0 (2024) |
| Gilead Sciences, Inc. | $80,938 | 279 | $0 (2024) |
| Merck Sharp & Dohme LLC | $1,053 | 63 | $0 (2024) |
| Janssen Biotech, Inc. | $899.07 | 79 | $0 (2023) |
| ABBVIE INC. | $888.33 | 40 | $0 (2024) |
| Janssen Products, LP | $719.31 | 8 | $0 (2022) |
| Otsuka America Pharmaceutical, Inc. | $644.07 | 32 | $0 (2024) |
| EMD Serono, Inc. | $595.15 | 35 | $0 (2024) |
| Napo Pharmaceuticals Inc | $398.08 | 23 | $0 (2024) |
| Amgen Inc. | $382.79 | 19 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $153,050 | 282 | ViiV Healthcare Company ($127,532) |
| 2023 | $132,866 | 259 | ViiV Healthcare Company ($98,363) |
| 2022 | $88,203 | 201 | ViiV Healthcare Company ($77,075) |
| 2021 | $67,793 | 155 | ViiV Healthcare Company ($60,326) |
| 2020 | $49,205 | 96 | ViiV Healthcare Company ($45,079) |
| 2019 | $85,722 | 177 | ViiV Healthcare Company ($84,403) |
| 2018 | $4,662 | 98 | Gilead Sciences, Inc. ($3,319) |
| 2017 | $1,012 | 61 | ViiV Healthcare Company ($269.62) |
All Payment Transactions
1,329 individual payment records from CMS Open Payments — Page 1 of 54
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/30/2024 | ViiV Healthcare Company | DOVATO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,900.00 | General |
| Category: HIV | ||||||
| 12/20/2024 | ViiV Healthcare Company | DOVATO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,900.00 | General |
| Category: HIV | ||||||
| 12/20/2024 | ViiV Healthcare Company | DOVATO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,950.00 | General |
| Category: HIV | ||||||
| 12/17/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $15.30 | General |
| Category: PSYCHIATRY | ||||||
| 12/16/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $32.36 | General |
| Category: Neuropsychiatry | ||||||
| 12/16/2024 | ViiV Healthcare Company | CABENUVA (Biological) | Food and Beverage | In-kind items and services | $17.45 | General |
| Category: HIV | ||||||
| 12/16/2024 | ViiV Healthcare Company | CABENUVA (Biological) | Food and Beverage | In-kind items and services | $3.65 | General |
| Category: HIV | ||||||
| 12/12/2024 | ViiV Healthcare Company | DOVATO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,900.00 | General |
| Category: HIV | ||||||
| 12/12/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $29.34 | General |
| 12/10/2024 | Gilead Sciences, Inc. | Biktarvy (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $400.00 | General |
| Category: HIV | ||||||
| 11/25/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $21.36 | General |
| 11/21/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $27.94 | General |
| 11/19/2024 | ViiV Healthcare Company | APRETUDE (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,900.00 | General |
| Category: HIV | ||||||
| 11/19/2024 | ViiV Healthcare Company | DOVATO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,900.00 | General |
| Category: HIV | ||||||
| 11/19/2024 | ViiV Healthcare Company | DOVATO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,950.00 | General |
| Category: HIV | ||||||
| 11/18/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $29.84 | General |
| Category: NEUROSCIENCE | ||||||
| 11/14/2024 | Merck Sharp & Dohme LLC | PIFELTRO (Drug), DELSTRIGO | Food and Beverage | In-kind items and services | $30.39 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 11/14/2024 | ViiV Healthcare Company | CABENUVA (Biological) | Food and Beverage | In-kind items and services | $22.26 | General |
| Category: HIV | ||||||
| 11/14/2024 | ViiV Healthcare Company | CABENUVA (Biological) | Food and Beverage | In-kind items and services | $5.25 | General |
| Category: HIV | ||||||
| 11/12/2024 | Napo Pharmaceuticals Inc | Mytesi (Drug) | Food and Beverage | Cash or cash equivalent | $16.23 | General |
| Category: Infectious Disease | ||||||
| 11/08/2024 | ViiV Healthcare Company | DOVATO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,900.00 | General |
| Category: HIV | ||||||
| 11/07/2024 | ViiV Healthcare Company | DOVATO (Drug) | Travel and Lodging | In-kind items and services | $315.60 | General |
| Category: HIV | ||||||
| 11/07/2024 | ViiV Healthcare Company | DOVATO (Drug) | Travel and Lodging | In-kind items and services | $171.35 | General |
| Category: HIV | ||||||
| 11/07/2024 | ViiV Healthcare Company | DOVATO (Drug) | Food and Beverage | In-kind items and services | $108.40 | General |
| Category: HIV | ||||||
| 11/07/2024 | ViiV Healthcare Company | CABENUVA (Biological) | Food and Beverage | In-kind items and services | $3.32 | General |
| Category: HIV | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 1 | 30 | 33 | $6,694 | $1,370 |
| 2022 | 2 | 59 | 89 | $16,236 | $4,628 |
| 2021 | 4 | 110 | 151 | $24,082 | $8,210 |
| 2020 | 4 | 193 | 246 | $38,973 | $11,743 |
Total Patients
392
Total Services
519
Medicare Billing
$25,951
Procedure Codes
11
All Medicare Procedures & Services
11 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 30 | 33 | $6,694 | $1,370 | 20.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 46 | 76 | $15,352 | $4,354 | 28.4% |
| 90686 | Influenza vaccine, quadrivalent, preservative free, 0.5 ml dosage | Office | 2022 | 13 | 13 | $884.00 | $274.17 | 31.0% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 58 | 97 | $19,900 | $6,646 | 33.4% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 13 | 15 | $2,070 | $666.65 | 32.2% |
| 90756 | Vaccine for influenza derived from cell cultures for injection into muscle, quadrivalent, antibiotic free, 0.5ml dosage | Office | 2021 | 21 | 21 | $1,428 | $595.10 | 41.7% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 18 | 18 | $684.00 | $302.13 | 44.2% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2020 | 71 | 105 | $12,959 | $6,993 | 54.0% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 54 | 71 | $21,584 | $3,158 | 14.6% |
| 90756 | Vaccine for influenza for injection into muscle | Office | 2020 | 39 | 40 | $2,720 | $1,097 | 40.3% |
| G0008 | Administration of influenza virus vaccine | Office | 2020 | 29 | 30 | $1,710 | $494.58 | 28.9% |
About Dr. Stephen Adams, MD
Dr. Stephen Adams, MD is a Family Medicine healthcare provider based in Springfield, Missouri. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/13/2007. The National Provider Identifier (NPI) number assigned to this provider is 1245363993.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Stephen Adams, MD has received a total of $582,513 in payments from pharmaceutical and medical device companies, with $153,050 received in 2024. These payments were reported across 1,329 transactions from 38 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($449,430).
As a Medicare-enrolled provider, Adams has provided services to 392 Medicare beneficiaries, totaling 519 services with total Medicare billing of $25,951. Data is available for 4 years (2020–2023), covering 11 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Springfield, MO
- Active Since 03/13/2007
- Last Updated 06/20/2013
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1245363993
Products in Payments
- DOVATO (Drug) $374,830
- APRETUDE (Biological) $112,944
- Biktarvy (Drug) $61,845
- Sunlenca (Drug) $3,101
- TIVICAY (Drug) $1,023
- SYMTUZA (Drug) $876.85
- VRAYLAR (Drug) $841.64
- JULUCA (Drug) $623.09
- REXULTI (Drug) $568.74
- PIFELTRO (Drug) $485.58
- Mytesi (Drug) $398.08
- ISENTRESS (Drug) $376.48
- PREZCOBIX (Drug) $373.26
- Symtuza (Drug) $358.47
- INGREZZA (Drug) $327.68
- TRIUMEQ (Drug) $325.94
- Repatha (Biological) $303.02
- RUKOBIA (Drug) $242.30
- SEROSTIM (Biological) $239.34
- CAPLYTA (Drug) $212.00
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Springfield
Dennis Morrison, Do, DO
Family Medicine — Payments: $404,412
Family Medicine $404,412
Dr. Roger Cady, Md, MD
Family Medicine — Payments: $175,721
Family Medicine $175,721
Dr. Ali Bajwa, M.d, M.D
Family Medicine — Payments: $169,373
Family Medicine $169,373
Dr. Christopher Davis, Do, DO
Family Medicine — Payments: $124,570
Family Medicine $124,570
John Wang, Do, DO
Family Medicine — Payments: $101,935
Family Medicine $101,935
Dr. William Warning, Md, MD
Family Medicine — Payments: $60,578
Family Medicine $60,578